Dr. Teeny studies various health conditions with a focus on how metabolic factors and environmental influences impact diseases. He specifically investigates liver diseases such as primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), where he has found that gut bacteria can affect liver health. In addition, he explores weight gain issues in women with HIV who start taking integrase strand transfer inhibitors (INSTIs) and examines how amino acid levels during pregnancy may link to future breast cancer risks. His research aims to provide insights that could lead to better strategies for preventing and treating these conditions.
Key findings
Patients with PSC and PBC had lower gut bacteria diversity and higher harmful bacteria, correlated with severe liver issues, indicating a potential target for new therapies.
In a study of women with HIV, those who gained at least 5% of their weight after starting INSTIs showed metabolic changes, indicating the need for tailored treatment approaches.
Lower amino acid levels during pregnancy were associated with a higher risk of breast cancer diagnosed within 15 years after delivery, suggesting a possible preventive measure through nutritional management.
Exposure to specific environmental chemicals during pregnancy was linked to later breast cancer diagnosis, revealing new potential risks like an insecticide and a common commercial product.
Higher levels of thiamine in critically ill patients were connected to improved energy metabolism, which may inform recovery strategies in intensive care.
Frequently asked questions
Does Dr. Teeny study breast cancer?
Yes, he studies how environmental factors and amino acid levels during pregnancy may impact the risk of developing breast cancer.
What treatments has Dr. Teeny researched?
He researches potential new therapies targeting gut microbiome alterations in liver disease and addresses weight gain in women with HIV related to specific medications.
Is Dr. Teeny's work relevant for women with HIV?
Yes, his research investigates the metabolic changes in women with HIV, especially concerning weight gain linked to INSTI treatments.
How does Dr. Teeny's research benefit pregnant women?
His studies highlight potential nutritional and environmental risks associated with breast cancer, aiding expectant mothers in making informed health choices.
What conditions does Dr. Teeny focus on?
He primarily focuses on liver diseases, breast cancer, and issues related to weight gain in women with HIV.
Publications in plain English
Altered Lipid and Neurotransmitter Metabolism as Potential Mechanisms of Weight Gain in Women With HIV Initiating INSTIs in a Pilot Study.
2026
Journal of acquired immune deficiency syndromes (1999)
Alvarez JA, Teeny S, Yang CA, Mehta CC, Yang Q +7 more
Plain English This study looked at why some women with HIV gain weight when they start taking a specific type of medication called integrase strand transfer inhibitors (INSTIs). Researchers examined blood samples from 33 women over a period of 6 to 12 months before starting INSTIs and again 1 to 6 months after starting the treatment. They found that women who gained at least 5% of their weight (an average of about 9.2 kg) showed notable changes in their metabolism compared to those who maintained or lost weight, particularly with changes in fat and nutrient processing.
Who this helps: This research supports doctors and healthcare providers in understanding weight gain in women with HIV who begin INSTI treatment.
Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease.
2026
Gut microbes
Nikolaidis M, Hu C, Juran BD, McCauley BM, Schlicht EM +24 more
Plain English This study looked at two uncommon liver diseases, primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), by analyzing gut bacteria and other substances in patients' stool samples. Researchers found that patients with these diseases had less variety in their gut bacteria and more harmful bacteria, which affected their metabolism. Specifically, those with PSC and PBC had lower levels of beneficial short-chain fatty acids and B-vitamins, and harmful bacteria were linked to worsening liver health while beneficial ones seemed to offer protection.
Who this helps: This research benefits patients suffering from PSC and PBC by identifying potential new treatments.
Environmental basis for early onset breast cancer.
2025
Reproductive toxicology (Elmsford, N.Y.)
Teeny S, Jarrell ZR, Krigbaum NY, Cirillo PM, Go YM +2 more
Plain English This study looked at the link between certain amino acids in the blood of pregnant women and the risk of developing breast cancer later on. Researchers found that women who were later diagnosed with breast cancer had lower levels of specific amino acids, like histidine and lysine, during their third trimester. This is important because it means that lower amino acid levels could be one way that environmental factors, like exposure to chemicals, may increase breast cancer risk.
Who this helps: This helps expectant mothers and healthcare providers understand potential risks related to environmental exposures during pregnancy.
High-resolution plasma metabolomics and thiamine status in critically Ill adult patients.
2024
Metabolomics : Official journal of the Metabolomic Society
Gundogan K, Nellis MM, Ozer NT, Ergul SS, Sahin GG +7 more
Plain English This study looked at how levels of thiamine, a crucial vitamin, affect the metabolism of critically ill adult patients. Researchers found that the concentration of thiamine in the blood was significantly linked to various metabolic pathways related to energy use and nutrient processing, with specific pathways identified several times in their analysis. This information is important because it helps to understand how thiamine status could impact patient recovery in intensive care, potentially guiding better treatment strategies.
Who this helps: This helps critically ill patients by improving their care and recovery strategies.
Exposome Epidemiology for Suspect Environmental Chemical Exposures during Pregnancy Linked to Subsequent Breast Cancer Diagnosis.
2023
medRxiv : the preprint server for health sciences
Go YM, Weinberg J, Teeny S, Cirillo P, Krigbaum N +4 more
Plain English This study looked at potential environmental chemicals that pregnant women might be exposed to and their link to developing breast cancer later. Researchers analyzed samples from 182 women who developed breast cancer and 384 women who didn't, discovering that certain chemicals, like an insecticide and a commercial product called DNP, were associated with breast cancer risk during pregnancy. This is important because it reveals new possible risks for breast cancer, helping us understand how certain environmental factors may contribute to this disease.
Who this helps: This helps patients, particularly expectant mothers, by highlighting environmental risks associated with breast cancer.
Exposome epidemiology for suspect environmental chemical exposures during pregnancy linked to subsequent breast cancer diagnosis.
2023
Environment international
Go YM, Weinberg J, Teeny S, Cirillo PM, Krigbaum NY +4 more
Plain English This study investigated how certain environmental chemicals exposure during pregnancy might be linked to breast cancer later on. Researchers analyzed samples from 182 women who developed breast cancer and 384 women who did not. They found connections between breast cancer and chemicals related to inflammation pathways, discovering new potential risks like an insecticide and a common commercial product.
Who this helps: This helps expectant mothers and doctors by highlighting potential chemical risks during pregnancy.
Third Trimester Serum Amino Acid Metabolism is Associated with Maternal Breast Cancer Diagnosed within 15 years of Pregnancy.
2023
Research square
Teeny S, Jarrell ZR, Krigbaum NY, Cirillo PM, Go YM +2 more
Plain English Researchers studied the blood samples of women in their third trimester of pregnancy to see if amino acid levels were linked to early onset breast cancer diagnosed within 15 years after pregnancy. They found that women who later developed breast cancer had lower levels of certain amino acids like histidine, threonine, and proline, along with changes in certain metabolic pathways associated with cancer risk. This matters because it suggests that nutrient levels during late pregnancy might play a role in the development of breast cancer shortly after childbirth.
Who this helps: This helps doctors and researchers understand potential risk factors for early onset breast cancer in new mothers.
High-Resolution Plasma Metabolomics and Thiamine Status in Critically Ill Adult Patients.
2023
Research square
Gundogan K, Nellis MM, Ozer NT, Ergul SS, Sahin GG +7 more
Plain English This study looked at the relationship between thiamine (a crucial vitamin for energy metabolism) levels in the blood and various metabolites in critically ill adults. The researchers found that higher thiamine levels were linked to specific metabolic pathways related to energy production and the breakdown of amino acids and fats. This is important because it highlights how thiamine status can influence energy metabolism in seriously ill patients, which could affect their recovery.
Who this helps: This helps critically ill patients and their healthcare providers.
Dean P Jones Young-Mi Go Jessica A Alvarez Thomas R Ziegler Nickilou Y Krigbaum Piera M Cirillo Barbara A Cohn ViLinh Tran Zachery R Jarrell Kursat Gundogan
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.